Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure

DMM Disease Models and Mechanisms

Volumn 6, Issue 4, 2013, Pages 1012-1020

  Collino, Massimo ^a   Pini, Alessandro ^b   Mugelli, Niccolò ^b   Mastroianni, Rosanna ^b   Bani, Daniele ^b   Fantozzi, Roberto ^a   Papucci, Laura ^b   Fazi, Marilena ^b   Masini, Emanuela ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; CASPASE 3; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PROTEIN BAX; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DAMAGE; ENZYME ACTIVATION; HEART FAILURE; HEART INFARCTION SIZE; HEART PROTECTION; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TREATMENT RESISTANT DEPRESSION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CARBON MONOXIDE; DISEASE MODELS, ANIMAL; DNA DAMAGE; ENZYME ACTIVATION; FREE RADICALS; HEART FAILURE; HEART FUNCTION TESTS; HEART VENTRICLES; HEME OXYGENASE-1; HEMIN; LEUKOCYTES; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; RATTUS;

EID: 84880020046     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.011528     Document Type: Article

References (43)

1. Abraham, N. G. and Kappas, A. (2005). Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 39, 1-25. (Pubitemid 40733115)
2. Aruoma, O. I., Halliwell, B., Laughton, M. J., Quinlan, G. J. and Gutteridge, J. M. (1989). The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complex. Biochem. J. 258, 617-620. (Pubitemid 19075542)
3. Bani, D., Masini, E., Bello, M. G., Bigazzi, M. and Sacchi, T. B. (1998). Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am. J. Pathol. 152, 1367-1376. (Pubitemid 28221889)
4. Breimer, L. H., Spyropolous, K. A., Winder, A. F., Mikhailidis, D. P. and Hamilton, G. (1994). Is bilirubin protective against coronary artery disease? Clin. Chem. 40, 1987-1988. (Pubitemid 24332717)
5. Brennan, D. C., Agha, I., Bohl, D. L., Schnitzler, M. A., Hardinger, K. L., Lockwood, M., Torrence, S., Schuessler, R., Roby, T., Gaudreault-Keener, M. et al. (2005). Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am. J. Transplant. 5, 582-594. (Pubitemid 40313351)
6. Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M. and Soares, M. P. (2000). Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192, 1015-1026.
7. Cai, C., Teng, L., Vu, D., He, J. Q., Guo, Y., Li, Q., Tang, X. L., Rokosh, G., Bhatnagar, A. and Bolli, R. (2012). The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J. Biol. Chem. 287, 33720-33732.
8. Chen, Z., Chua, C. C., Ho, Y. S., Hamdy, R. C. and Chua, B. H. (2001). Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 280, H2313-H2320.
9. Collino, M., Thiemermann, C., Mastrocola, R., Gallicchio, M., Benetti, E., Miglio, G., Castiglia, S., Danni, O., Murch, O., Dianzani, C. et al. (2008). Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 30, 299-307.
10. Fang, J., Qin, H., Seki, T., Nakamura, H., Tsukigawa, K., Shin, T. and Maeda, H. (2011). Therapeutic potential of pegylated hemin for reactive oxygen species-related diseases via induction of heme oxygenase-1: results from a rat hepatic ischemia/reperfusion injury model. J. Pharmacol. Exp. Ther. 339, 779-789.
11. Ferenbach, D. A., Kluth, D. C. and Hughes, J. (2010). Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp. Nephrol. 115, e33-e37.
12. Giannini, L., Vannacci, A., Fabrizi, F., Uliva, C., Bani, D., Masini, E. and Mannaioni, P. F. (2005). Protection from cardiac injury by induction of heme oxygenase-1 and nitric oxide synthase in a focal ischaemia-reperfusion model. Cell Mol Biol 51, 393-401. (Pubitemid 41596317)
13. Grinshtein, N., Bamm, V. V., Tsemakhovich, V. A. and Shaklai, N. (2003). Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. Biochemistry 42, 6977-6985. (Pubitemid 36706480)
14. Kim, H. P., Wang, X., Zhang, J., Suh, G. Y., Benjamin, I. J., Ryter, S. W. and Choi, A. M. (2005). Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J. Immunol. 175, 2622-2629. (Pubitemid 41113876)
15. Kumar, S. and Bandyopadhyay, U. (2005). Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157, 175-188. (Pubitemid 40726102)
16. Lakkisto, P., Csonka, C., Fodor, G., Bencsik, P., Voipio-Pulkki, L. M., Ferdinandy, P. and Pulkki, K. (2009). The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43. Scand. J. Clin. Lab. Invest. 69, 209-218.
17. Llesuy, S. F. and Tomaro, M. L. (1994). Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim. Biophys. Acta 1223, 9-14. (Pubitemid 24262847)
18. Maines, M. D. (1997). The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554.
19. Masini, E., Cuzzocrea, S., Mazzon, E., Marzocca, C., Mannaioni, P. F. and Salvemini, D. (2002). Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br. J. Pharmacol. 136, 905-917. (Pubitemid 34836865)
20. Masini, E., Vannacci, A., Marzocca, C., Pierpaoli, S., Giannini, L., Fantappié, O., Mazzanti, R. and Mannaioni, P. F. (2003). Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp. Biol. Med. (Maywood) 228, 546-549. (Pubitemid 37203675)
21. Masini, E., Bani, D., Vannacci, A., Pierpaoli, S., Mannaioni, P. F., Comhair, S. A., Xu, W., Muscoli, C., Erzurum, S. C. and Salvemini, D. (2005). Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic. Biol. Med. 39, 520-531. (Pubitemid 41021650)
22. Mayer, M. (2000). Association of serum bilirubin concentration with risk of coronary artery disease. Clin. Chem. 46, 1723-1727.
23. Morse, D., Pischke, S. E., Zhou, Z., Davis, R. J., Flavell, R. A., Loop, T., Otterbein, S. L., Otterbein, L. E. and Choi, A. M. (2003). Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J. Biol. Chem. 278, 36993-36998. (Pubitemid 37175212)
24. Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F. D., Dal Bello, B., Semigran, M. J., Bielsa-Masdeu, A., Dec, G. W. et al. (1999). Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. USA 96, 8144-8149. (Pubitemid 29328422)
25. Nath, K. A. and Katusic, Z. S. (2012). Vasculature and kidney complications in sickle cell disease. J. Am. Soc. Nephrol. 23, 781-784.
26. Ndisang, J. F., Wang, R., Vannacci, A., Marzocca, C., Fantappiè, O., Mazzanti, R., Mannaioni, P. F. and Masini, E. (2001). Haeme oxygenase-1 and cardiac anaphylaxis. Br. J. Pharmacol. 134, 1689-1696. (Pubitemid 34038102)
27. Novo, G., Cappello, F., Rizzo, M., Fazio, G., Zambuto, S., Tortorici, E., Marino Gammazza, A., Corrao, S., Zummo, G., De Macario, E. C. et al. (2011). Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl. Res. 157, 285-292.
28. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A. and Choi, A. M. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428. (Pubitemid 30208159)
29. Peterson, S. J., Frishman, W. H. and Abraham, N. G. (2009). Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol. Rev. 17, 99-111.
30. Petrache, I., Otterbein, L. E., Alam, J., Wiegand, G. W. and Choi, A. M. (2000). Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L312-L319. (Pubitemid 30131216)
31. Stennicke, H. R. and Salvesen, G. S. (1997). Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem. 272, 25719-25723. (Pubitemid 27438890)
32. Tang, Y. L., Tang, Y., Zhang, Y. C., Qian, K., Shen, L. and Phillips, M. I. (2004). Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension 43, 746-751. (Pubitemid 38405581)
33. Tarquini, R., Masini, E., La Villa, G., Barletta, G., Novelli, M., Mastroianni, R., Romanelli, R. G., Vizzutti, F., Santosuosso, U. and Laffi, G. (2009). Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. Am. J. Gastroenterol. 104, 891-897.
34. Tsiftsoglou, A. S., Tsamadou, A. I. and Papadopoulou, L. C. (2006). Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol. Ther. 111, 327-345. (Pubitemid 43832008)
35. Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V. and Snyder, S. H. (1993). Carbon monoxide: a putative neural messenger. Science 259, 381-384. (Pubitemid 23055683)
36. Wang, R., Wu, L. and Wang, Z. (1997). The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch. 434, 285-291. (Pubitemid 27276232)
37. Wang, X. M., Kim, H. P., Nakahira, K., Ryter, S. W. and Choi, A. M. (2009). The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol. 182, 3809-3818.
38. Wang, G., Hamid, T., Keith, R. J., Zhou, G., Partridge, C. R., Xiang, X., Kingery, J. R., Lewis, R. K., Li, Q., Rokosh, D. G. et al. (2010). Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121, 1912-1925.
39. Yeh, C. H., Chen, T. P., Wang, Y. C., Lin, Y. M. and Lin, P. J. (2009). HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion. J. Surg. Res. 155, 147-156.
40. Yet, S. F., Tian, R., Layne, M. D., Wang, Z. Y., Maemura, K., Solovyeva, M., Ith, B., Melo, L. G., Zhang, L., Ingwall, J. S. et al. (2001). Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ. Res. 89, 168-173. (Pubitemid 34135825)
41. Yoshida, T., Maulik, N., Ho, Y. S., Alam, J. and Das, D. K. (2001). H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 103, 1695-1701. (Pubitemid 32246619)
42. Zhang, X., Shan, P., Alam, J., Davis, R. J., Flavell, R. A. and Lee, P. J. (2003). Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J. Biol. Chem. 278, 22061-22070. (Pubitemid 36792616)
43. Zuckerbraun, B. S., Otterbein, L. E., Boyle, P., Jaffe, R., Upperman, J., Zamora, R. and Ford, H. R. (2005). Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G607-G613. (Pubitemid 41216400)